No Detail Found!

Changes in Serum Copeptin and Sphingosine 1-Phosphate in Patients with Restenosis after Stent Implantation of Symptomatic Intracranial Artery Stenosis

Author(s)
Xuzhang Jiao Department of Neurology, Changyi People's Hospital,Shandong Province,China
Zhifeng Li Department of Neurology, Changyi People's Hospital,Shandong Province,China
Senlin Wang Department of Neurology, Changyi People's Hospital,Shandong Province,China
Abstract
Objective: To determine the changes of serum copeptin and sphingosine 1-phosphate (S1P) in patients with restenosis after stent implantation of symptomatic intracranial artery stenosis. Study Design: An observational study. Place and Duration of Study: Changyi people's Hospital, China, from February 2016 to November 2019. Methodology: A total of 76 patients with symptomatic intracranial artery stenosis and stent implantation were divided into the restenosis group (n = 16) and the non-restenosis group (n=60) according to the intracranial artery restenosis occurred after the follow-up of 1 year. Levels of serum copeptin and S1P were compared between the groups. Result: There were signi cant di erences in diabetes mellitus and hypertension between the two groups (p<0.001 and p = 0.017, respectively). There were no signi cant di erences in serum copeptin and S1P levels between the two groups before and 3 days after the operation (p = 0.927, 0.792, 0.776, and 0.906, respectively). Postoperative follow-up of one year, levels of serum copeptin in the restenosis group were higher than those in the non-restenosis group (p<0.001), and levels of serum S1P in the restenosis group were lower than those in the non-restenosis group (p = 0.003). Conclusion: High serum copeptin level, low serum S1P level, hypertension, and diabetes mellitus are independent risk factors promoting restenosis after stent implantation in patients with symptomatic intracranial artery stenosis.
Publication Details
Page(s) 697-700
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 32, Issue: 6, Year: 2022

Request the full text from PASTIC

Keywords
Restenosis, Copeptin, Sphingosine 1-phosphate (S1P), Symptomatic intracranial artery stenosis, Stent implantation
0

Citations

0

Downloads

71

Views